fda compounding semaglutide crackdown news today 2025 Report: must enforce rules on compounded GLP-1s FDA Takes Aim at Hims

Engineered for Severe Obesity and Complex Metabolic Disorders Retatrutides triple-agonist model is intended to help individuals with strong metabolic resistance, such as those who: plateau on semaglutide struggle with long-term weight maintenance experience rapid metabolic slowdown during dieting have severe insulin resistance or fatty liver issues Potential Beyond Weight Management Ongoing studies are exploring retatrutides ability to improve: insulin sensitivity liver-fat clearance cardiovascular risk markers inflammatory markers stabilization of long-term metabolic function These features suggest retatrutide may evolve into a broader therapeutic option than current GLP-1 drugs

Those wanting product that works beyond the surface, at the cellular level

One safety note specific to Levity: their compounded semaglutide includes glycine and B12

Shop here

A category favorite among Vogue editors, CurrentBodys RF Radio-Frequency Skin-Tightening Device sends radio waves into the dermal layers of the skin, where collagen is formed

Usually, it speeds up metabolism